Literature DB >> 22752724

RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.

German Melean1, Ana Velasco, Elisabete Hernández-Imaz, Francisco Javier Rodríguez-Álvarez, Yolanda Martín, Ana Valero, Concepción Hernández-Chico.   

Abstract

Germline mutations in the SMARCB1 gene cause familial schwannomatosis, a condition characterized by the presence of multiple schwannomas, although mutations in SMARCB1 have also been associated with rhadboid tumor predisposition syndrome 1 (RTPS1). Both schwannomatosis and RTPS1 are autosomal dominant conditions that predispose individuals to develop distinct types of tumors. We clinically and genetically characterized two families with schwannomatosis associated with SMARCB1 mutations. Eight affected members of these families developed different numbers of schwannomas and/or meningiomas at distinct ages, evidence that meningiomas are variably expressed in this condition. We identified two germline mutations in SMARCB1 associated with the familial disease, c.233-1G>A and the novel c.207_208dupTA mutation, which both proved to affect the main SMARCB1 isoforms at the RNA level distinctly. Interestingly, the c.207_208dupTA mutation had no effect on the coding sequence, pre-mRNA splicing or the level of expression of the SMARCB1 isoform 2. Furthermore, SMARCB1 isoforms harboring a premature termination codon were largely eliminated via the nonsense-mediated mRNA decay pathway. Our results highlight the importance of RNA-based studies to characterize SMARCB1 germline mutations in order to determine their impact on protein expression and gain further insight into the genetic basis of conditions associated with SMARCB1 mutations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752724     DOI: 10.1007/s10048-012-0335-8

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  21 in total

1.  Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis.

Authors:  Miriam J Smith; Andrew J Wallace; Naomi L Bowers; Cecilie F Rustad; C Geoff Woods; Guy D Leschziner; Rosalie E Ferner; D Gareth R Evans
Journal:  Neurogenetics       Date:  2012-03-22       Impact factor: 2.660

2.  Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.

Authors:  Miriam J Smith; Anjana Kulkarni; Cecilie Rustad; Naomi L Bowers; Andrew J Wallace; Susan E Holder; Arvid Heiberg; Richard T Ramsden; D Gareth Evans
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

3.  Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint.

Authors:  Robert G J Vries; Vladimir Bezrookove; Lobke M P Zuijderduijn; Sima Kheradmand Kia; Ada Houweling; Igor Oruetxebarria; Anton K Raap; C Peter Verrijzer
Journal:  Genes Dev       Date:  2005-03-15       Impact factor: 11.361

4.  Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers.

Authors:  N Sévenet; E Sheridan; D Amram; P Schneider; R Handgretinger; O Delattre
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

5.  Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.

Authors:  I Christiaans; S B Kenter; H C Brink; T A M van Os; F Baas; P van den Munckhof; A M J Kidd; T J M Hulsebos
Journal:  J Med Genet       Date:  2010-10-07       Impact factor: 6.318

6.  Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis.

Authors:  K D Hadfield; W G Newman; N L Bowers; A Wallace; C Bolger; A Colley; E McCann; D Trump; T Prescott; D G R Evans
Journal:  J Med Genet       Date:  2008-02-19       Impact factor: 6.318

7.  Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation.

Authors:  Costanza Bacci; Roberta Sestini; Aldesia Provenzano; Irene Paganini; Irene Mancini; Berardino Porfirio; Rossella Vivarelli; Maurizio Genuardi; Laura Papi
Journal:  Neurogenetics       Date:  2009-07-07       Impact factor: 2.660

8.  High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML.

Authors:  Manuel Favre; Christophe Butticaz; Brian Stevenson; C Victor Jongeneel; Amalio Telenti
Journal:  J Acquir Immune Defic Syndr       Date:  2003-10-01       Impact factor: 3.731

Review 9.  Genomic variants in exons and introns: identifying the splicing spoilers.

Authors:  Franco Pagani; Francisco E Baralle
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

10.  SNF5, a core component of the SWI/SNF complex, is necessary for p53 expression and cell survival, in part through eIF4E.

Authors:  Y Xu; W Yan; X Chen
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

View more
  3 in total

1.  SWI/SNF chromatin remodeling complex alterations in meningioma.

Authors:  Corey M Gill; Joshua Loewenstern; John W Rutland; Hanane Arib; Margaret Pain; Melissa Umphlett; Yayoi Kinoshita; Russell B McBride; Joshua Bederson; Michael Donovan; Robert Sebra; Mary Fowkes; Raj K Shrivastava
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-14       Impact factor: 4.553

Review 2.  Diagnostic Pathology of Tumors of Peripheral Nerve.

Authors:  Sarra M Belakhoua; Fausto J Rodriguez
Journal:  Neurosurgery       Date:  2021-02-16       Impact factor: 4.654

Review 3.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.